Haemonetics
297 hedge funds and large institutions have $4.37B invested in Haemonetics in 2024 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 104 increasing their positions, 115 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
297
Holders Change
+2
Holders Change %
+0.68%
% of All Funds
4.3%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
42
Increased
104
Reduced
115
Closed
40
Calls
$14.6M
Puts
$5.04M
Net Calls
+$9.59M
Net Calls Change
-$1.66M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$85.6M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
+$38.7M |
| 3 |
RA
Royce & Associates
New York
|
+$25.6M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$24.5M |
| 5 |
Neuberger Berman Group
New York
|
+$21.9M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$118M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$52.6M |
| 3 |
Morgan Stanley
New York
|
-$48.4M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$25.6M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$22.7M |
